Andrea Calcagno
Expertise in
4
conditions

Andrea Calcagno

Novara, IT 
Expertise in
4
conditions
Novara, IT 

Overview

Andrea Calcagno practices practicing medicine in Novara, Italy.

Ms. Calcagno is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, AIDS Dementia Complex, Progressive Multifocal Leukoencephalopathy, and Severe Acute Respiratory Syndrome (SARS).

She is actively involved in clinical research, co-authoring 285 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Novara, 28100, Italy
Other Locations
Milan, Italy
Turin, Italy
Genoa, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

MARaviroc-based Treatment Switch in HIV-positive Patients With HAND: Consequences of Reducing Antiretroviral-associated Neurotoxicity
MARaviroc-based Treatment Switch in HIV-positive Patients With HAND: Consequences of Reducing Antiretroviral-associated Neurotoxicity
Enrollment Status: Terminated
Publish Date: November 06, 2020
Intervention Type: Drug
Study Phase: Phase 4
Switching HIV-positive Women on Tenofovir/Emtricitabine Plus Boosted Atazanavir to RALtegravir Plus Boosted ATazanavir: A Pilot Randomized Clinical Trial Investigating 48-weeks Changes in Bone Mineral Density
Switching HIV-positive Women on Tenofovir/Emtricitabine Plus Boosted Atazanavir to RALtegravir Plus Boosted ATazanavir: A Pilot Randomized Clinical Trial Investigating 48-weeks Changes in Bone Mineral Density
Enrollment Status: Terminated
Publish Date: October 17, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

285 Total Publications

Individualized TB care for drug-susceptible pulmonary tuberculosis: clinical alternatives when HRZE is contraindicated or not tolerated.
Individualized TB care for drug-susceptible pulmonary tuberculosis: clinical alternatives when HRZE is contraindicated or not tolerated.
Journal: Expert review of respiratory medicine
Published: May 29, 2026

Frequently Asked Questions about Andrea Calcagno

Is Andrea Calcagno a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Andrea Calcagno is classified as an Elite expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Andrea Calcagno participate in research or clinical trials?

Yes. Andrea Calcagno has published 285 articles and abstracts on conditions like HIV/AIDS. You can view a list of Andrea Calcagno's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Calcagno's expertise for a condition
ConditionClose
View All 44 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile